Requests similar to 'Medsafe Data on Graphene Oxide Discovered in the Product Septanest'
Kia ora,
Please find attached the response for your request for official
information.
Ngā mihi
OIA Services Team
Manatū Hauor...
It is a human right, and global law governed under the Nuremberg Code, that vaccine specific ingredient information is disclosed. It is critical, r...
Presence of Nanotechnology in Pfizer COVID-19 "Vaccine"
Response by Ministry of Health to Peter Russell on .
Long overdue.
Kia ora Peter,
Thank you for your follow up email.
The Pfizer vaccine does not contain graphene. This issue has been
extensively fact-checked by in...
Dear Mr McMahon,
Please find attached two PDF documents to accompany our response.
Kind regards,
Hayley Farrington | Contracts and In...
Pfizer Vaccine Ingredients
Response by University of Auckland to Chris McCashin on .
Information not held.
Dear Chris,
I refer to your request of 23 September 2021. The University of Auckland
has not tested the contents of the Pfizer vaccine.
Yo...
Pfizer Covid Vaccine Risk Benefit Analysis / Risk-Benefit Asessment
Response by Ministry of Health to M Bell on .
Partially successful.
Kia ora M Bell,
Thank you for your follow up request on 31 January 2024 for:
“You say that there is no specific document that demonstrates...
Kia ora M Bell,
Thank you for your request for information regarding COVID data leak on 17
January 2024. Please find attached our response to your...
Awareness of unintended sequelae post Pfizer mRNA vaccination (DNA contamination, SV40, IgG4 etc)
Response by Ministry of Health to Anna on .
Awaiting classification.
Kia ora Anna
Please find attached the response to your request for official
information.
Ngā mihi
OIA Services Team
Ministr...
Pfizer Vaccine Ingredients
Response by University of Otago to Chris McCashin on .
Information not held.
Kia ora Chris
Please see attached our response to your information request dated 23 September 2021 made under the Official Information Act 1982.
Ngā...
Sustainability Initiatives and Environmental Data
Response by Health New Zealand to Maddison Winsor on .
Awaiting classification.
Kia ora Maddison
Thank you for your request for information on 1 March 2025, please find
attached our response to your request.
If you have...
Kia ora,
Thank you for your email. The Ministry of Health (the Ministry) is unable
to provide this information to you and has been withheld in full u...
CV-ISMB all available Meeting Minutes, Rapid Cycle Analysis Reports
Response by Ministry of Health to M Bell on .
Partially successful.
Kia ora,
Thank you for your request for information. Please find attached our
response to your request.
If you have any questions, please get...
Differences between BNT162b2 and Comirnaty®
Response by Ministry of Health to ASE on .
Awaiting classification.
Kia ora ASE,
Please find attached our response to your official information request.
Ngā mihi
OIA Services Team
Manatū Hauora...
Hardys Daily Nutrients reclassified from dietary supplement to prescription medicine
Response by Ministry of Health to J Bruning on .
Partially successful.
Kia ora,
Please find attached the response for your request for official
information.
Ngā mihi
OIA Services Team
Manatū Hauor...
## 📌 Annotation for OIA #31214 – *Regulatory Assessment Processes Involved in Assessing the COVID-19 Pfizer Contract*
The Ministry of Health’s respon...
Epidemiologist Response to Steve Kisch Excess Death Analysis.
Response by Health New Zealand to M Bell on .
Information not held.
Kia ora M Bell
Thank you for your request for information regarding Epidemiologist
response to excess death analysis on 11 December. Please find...
Comirnaty (COVID-19 mRNA vaccine) with active ingredient BNT162b2
Request sent to Ministry of Health by Heather Darby on .
Refused.
Please provide any and all information that has been provided to the Ministry of Health or Medsafe pertaining to the product Comirnaty (COVID-19 mRN...
Kia ora,
Thank you for your email. Weekly reports summarising the number and type
of adverse events following immunisation (AEFI) reported with COVI...
Please Provide "Out of Scope" Portions Redacted From SROIA 032
Response by Shane Reti to M Bell on .
Refused.
Kia ora M Bell
Please find the response to your request for information attached.
Ngā mihi
Office of Hon Dr Shane Reti
Minister of...
Risk assessment of amyloidogenic segments by way of transfection
Response by Ministry of Health to R. Kingi on .
Refused.
Kia ora R Kingi,
Please find attached our response to your official information request.
Ngā mihi
OIA Services Team
Manatū Ha...
Hi Erika,
It appears impossible to get this information from MOH. Here is my attempt and I believe the fetal cells will be in that component of the v...
Medsafe Covid Vaccination Benefits and Risks Evaluation Results
Response by Ministry of Health to Peter on .
Awaiting classification.
Kia ora Peter,
Thank you for your request received by the Ministry of Health (the
Ministry) on 15 October 2021 for:
“The clin...
Pfizer Vaccine Consistency
Response by Ministry of Health to Chuck Schooner (Account suspended) on .
Refused.
Kia ora Chuck,
Further to our email below we will also be responding to the following
request under this reference: H202117155.
"Please state...
Vaccine Adverse Reaction Reporting Standards
Response by Ministry of Health to Mr M Bell on .
Long overdue.
Kia ora M Bell
Thank you for your correspondence received on 9 April 2021.
Adverse events following immunisation (AEFI) for the COVID-1...
Transfer of mRNA, Limit of Provisional Consent
Response by Ministry of Health to Mr M Bell on .
Long overdue.
Kia ora M Bell
Thank you for your email dated 17 April 2021.
Information in response to each part of your request is outlined below:...
